The association with risk of COPD exacerbation in CKB was not replicated in UKB using a different functional PCSK9 variant (see Supplementary material online, Table S10), although power was limited due to a much smaller number of recorded cases (468 in UKB vs. 2212 cases in CKB). This evidence concerns the gene PCSK9 and chronic obstructive pulmonary disease.